Skip to main content

Randomised Trials: The Case for Science in Medicine

  • Conference paper
Cancer Clinical Trials

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 111))

  • 120 Accesses

Abstract

It is quite apparent to me that very few people understand the meaning of the word “epistemology”. It may be difficult to pronounce but it is quite easy to understand. Epistemology is the study of the growth of knowledge, or “how do we know what we think we know”? What I would now like to try to get across is that scientific philosophy is not a rarefied activity indulged in by retired physicians who have nothing better to do with the remainder of their lives; rather, it is a very important aspect of medical education and medical practice. I will illustrate this by describing aspects of the growth of philosophy and how this has an impact on our everyday practice. I would like to start off with Aristotle, the Greek philosopher who was the father of inductivism. Inductivism is another word that is frequently used but not clearly understood. Simply put, inductivism is the process by which you generate a hypothesis and then seek corroborative evidence to prove that your hypothesis is an expression of the truth. The history of medicine is littered with the tragic failures of this philosophical approach. Galen, a second-century physician, was the master of inductivism in medical practice and his malign influence led to 1600 years of sterility. This sterility was not merely an inhibition of medical progress; it also included the perpetuation of barbaric and useless treatments such as that of bleeding and cupping, the panacea approaches for most ills up until the early years of the past century. To this day, you will meet contemporary inductivists pacing the marble corridors of ultramodern high-technology hospitals, introducing and perpetuating dangerous therapies without having the intellectual honesty to seek anything other than corroborative evidence in support of their ideas. I would now like to take you 1000 years further, to the birth of the deductive process in medical science. William of Okam was a thirteenth-century English monk, and his famous aphorism “Entiae non multiplicandum necessitatum” describes the philosophical underpinning of the modern approach to medical diagnosis. A loose translation of the Latin would be that on observing multiple phenomena you should try to explain your observations in terms of the simplest underlying cause. Thus, the whole process of diagnosis is the eliciting of symptoms and signs from the patient, and instead of coming up with multiple explana- tions for them we apply Okam’s razor to postulate a single causal explanation with multiple epiphenomena.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Baum M (1983) Quack cancer cures or scientific remedies? Clin Oncol 9: 275–280

    PubMed  CAS  Google Scholar 

  • Berstock DA, Houghton J, Haybittle J, Baum M (1985) The role of radiotherapy following total mastectomy for patients with early breast cancer. World J Surg 661–670

    Google Scholar 

  • Bonadonna G, Valagusa P (1981) Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 30: 10–15

    Article  Google Scholar 

  • Breasted JH (1930) The Edwin Smith papyrus. University of Chicago Press, Chicago, pp 403–406

    Google Scholar 

  • Cade Sir S (1948) Discussion: the treatment of cancer of the breast. Proc R Soc Med 41:129

    Google Scholar 

  • Cole MP (1970) Prophylactic compared with therapeutic X-ray artificial menopause, 2nd Tenovus Workshop on Breast Cancer. Alpha-Omega, Cardiff, pp 2–11

    Google Scholar 

  • Cuzick J, Baum M (1985) Tamoxifen and contralateral breast cancer. Lancet ii: 282

    Article  Google Scholar 

  • Cuzick J, Wang DY, Bulbrook RD (1986) The prevention of breast cancer. Lancet i: 83–86

    Article  Google Scholar 

  • De Moulin D (1983) In: A short history of cancer. Nyhoff, Boston

    Google Scholar 

  • Dunn AR (1986) Viral and cellular oncogenes a molecular basis for breast and other cancers. In: Forbes JF (ed) Breast disease, vol 5. Churchill Livingstone, Edinburgh, pp 59–68

    Google Scholar 

  • Fallowfield L, Baum M, Maguire GP (1986) The effects of breast conservation on the psychological morbidity associated with the diagnosis and treatment of early breast cancer. Br Med J (In press)

    Google Scholar 

  • Fisher B (1970) The surgical dilemma in the primary therapy of invasive breast cancer. A critical appraisal. In: Current problems in surgery. Year Book Publishers, Chicago

    Google Scholar 

  • Fisher B, Redmond C, Fisher ER (1980) The contribution of recent NSABP trials of primary breast cancer therapy to an understanding of tumour biology. Cancer 46: 1009

    Article  PubMed  CAS  Google Scholar 

  • Goldhirsch A, Gelber RD, Davis BW (1986) Adjuvant chemotherapy trials in breast cancer: an appraisal and lessons for patient care outside the trials. In: Forbes JF (ed) Breast disease, vol 10. Churchill Livingstone, Edinburgh, pp 123–138

    Google Scholar 

  • Gross SW (1880) A practical treatise of tumours of the mammary gland. Appleton, New York

    Google Scholar 

  • Halsted WS (1898) The radical operation for the cure of carcinoma of the breast. Johns Hopkins Hospital reports, no 28, p 557

    Google Scholar 

  • Keynes G (1937) Conservative treatment of cancer of the breast. Br Med J 643–647

    Google Scholar 

  • Kon OL (1983) An antiestrogen-binding protein in human tissues. J Biol Chem 258: 3173

    PubMed  CAS  Google Scholar 

  • Lippman ME, Bolan G (1975) Oestrogen-responsive human breast cancer in long-term tissue culture. Nature 256: 592–593

    Article  PubMed  CAS  Google Scholar 

  • Maguire P (1982) Psychiatric morbidity associated with mastectomy. In: Baum M, Kay R, Scheurlen H (eds) Clinical trial in early breast cancer, 2nd Heidelberg symposium. Birk-häuser, Basel, pp 373–380

    Google Scholar 

  • Meyer JS, Rao BR, Stevens SC, White WL (1977) Low incidence of oestrogen receptors in breast carcinoma with rapid rates of cellular replication. Cancer 40: 2290

    Article  PubMed  CAS  Google Scholar 

  • Nolvadex Adjuvant Trial Organisation (NATO) (1983) Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Interim analysis at 4 years by NATO. Lancet i: 257–261

    Google Scholar 

  • Nolvadex Adjuvant Trial Organisation (NATO) (1985 a) Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at 6 years by NATO. Lancet i:836–840

    Google Scholar 

  • Nolvadex Adjuvant Trial Organisation (NATO) (1985 b) Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. World J Surg 9: 756–764

    Article  Google Scholar 

  • Paterson RP, Russell MH (1959) Clinical trials in malignant disease. J Fac Radiol (Lond) 10:130

    Article  Google Scholar 

  • Popper KR (1959) The logic of scientific discovery. Hutchinson, London

    Google Scholar 

  • Rose DP, Davis TE (1977) Ovarian function in patients receiving adjuvant chemotherapy for breast cancer. Lancet i: 1174

    Article  Google Scholar 

  • Sainsbury JRC, Farndon JR, Sherbet GV, Harris AL (1985) Epidermal-growth factor receptors and oestrogen receptors in human breast cancer. Lancet i: 364–366

    Article  Google Scholar 

  • Steele RJC (1983) Clinical, histological and immunological studies in human breast cancer. MD thesis, University of Edinburgh

    Google Scholar 

  • Trivedi D (1986) Antigenic profile of human breast tumours. PhD thesis, University of London

    Google Scholar 

  • UK Breast Cancer Trials Cancer Coordinating Committee/UICC (1984) Review of mortality results in randomised trials in early breast cancer. Lancet ii: 1205

    Google Scholar 

  • Waterfield MD, Scrace GT, Whittle N, et al (1983) Platelet-derived growth factor is structurally related to the putative transforming protein p28 of simian sarcoma virus. Nature 304: 34

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Baum, M. (1988). Randomised Trials: The Case for Science in Medicine. In: Scheurlen, H., Kay, R., Baum, M. (eds) Cancer Clinical Trials. Recent Results in Cancer Research, vol 111. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83419-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83419-6_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83421-9

  • Online ISBN: 978-3-642-83419-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics